Search for: [Abstract = "ystolic and > 80 mmHg for diastolic blood pressure despite maximized medical treatment\), stenosis of the single functioning kidney \(for DBP improvement\), history of myocardial infarction \(for SBP improvement\), while documented history of ARAS progression reduces the chances of SBP improvement after PTA. 5. Long\-term MACCE affects a large proportion \(1 in 3\) patients, most likely as a result of the baseline risk burden. Independent predictors of MACCE identified in the present work are the following\: male gender, multivessel CAD, hyperlipidemia and concomitant atherosclerosis in the contralateral renal artery. CVD predictors include male gender, history of any previous revascularization or atherosclerotic lesions > 50% in at least 2 additional arterial territories, history of hypertensive crisis and concomitant atherosclerosis in the contralateral renal artery. 6. Improvement of outcome after PTA for RAS, manifested as a reduction of long\-term MACCE \(by 46%\) and in CVD \(by 58%\) is associated with an increase in eGFR exceeding 11 ml \/ min \/ 1.73 m2\; this can be achieved in a significant proportion \(ie, one in every four\) patients. Decrease in SBP by 20 mmHg or DBP by 5 mmHg 12 months after PTA is associated with a 90% reduction in the risk of ischemic stroke and can be achieved in, respectively, 46% and 35% of the successfully revascularized patients. 7. Restenosis rate is 14"]

Number of results: 1